June 25-27, 2019
FOCUSED AND TIMELY INFORMATION DELIVERED DIRECTLY TO YOU
2019 Webinar Series Line-up
Tuesday, June 25th
Synthetic DNA Technologies Enable Antibody Discovery and Optimization
Aaron K. Sato, Ph.D.
Twist Bioscience, Biopharma
Oncolytic Vaccines Encoding T Cell Engagers: Tumor-targeted Delivery and Anti-tumor Synergy
Christine E. Engeland, M.D., Ph.D.,
Physician-Scientist, Departments of Medical Oncology and Translational Oncology,
National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ)
Wednesday, June 26th
Accelerating target-to-lead antibody candidate selection using the Berkeley Lights Beacon Platform
Anupam Singhal, Ph.D.
Senior Manager, Technology Development
Berkeley Lights, Inc.
"Antibodies to Watch” and More: Early- and Late-stage Clinical Development Trends
Janice Reichert, Ph.D.
Managing Director, Reichert Biotechnology Consulting
Executive Director, The Antibody Society
Thursday, June 27th
Abzena Thought Leadership Session
CONNECT TO NEW IDEAS AND INNOVATIONS THROUGH WEBINARS
2018 Digital Content still available on-demand
Tumor Uptake of PEGylated Diabody: Balancing Between Antibody Size and Systemic Clearance
Therapeutic Targeting of Notch 3 Signaling for Cerebral Small Vessel Disease
High Throughput Characterization of Ion Channel Activity Blocking mAbs with Array SPR
DNA-based Antibody Therapy: A Blueprint for Innovation
New Ways to Boost Recombinant Protein and Antibody Yields in Transient Systems
High Resolution Protein and Antibody Modeling with NovaFold and NovaFold Antibody
Antibodies to Watch in 2018 Update
Emerging Technologies for Finding Rare Antibodies
Why Attend a Webinar?
Time and Cost-Efficient
You will save valuable time and money because there is no need to travel and no registration fee.
Focused and Timely Learning
You will receive the latest "hot" and timely data from a leading authority
You can participate in a webinar from a location of your choosing – your home, your office, or a client/customer location